Therefore, the results of this study suggested that visfatin-activated p38 signaling and Sp1 transcription factor are crucial elicitors to promote drug resistance of CRC cells through upregulating the TYMS expression. The gene discussed is NAMPT; the disease is colorectal carcinoma.